Table 5.
Group | Before inoculation of HX-140 | After inoculation of HX-140 | Control efficacy (%)a | ||
---|---|---|---|---|---|
Incidence rate (%)a | Disease indexa | Incidence rate (%)a | Disease indexa | ||
CK | 28.57 ± 1.03 a | 7.44 ± 0.68 a | 76.19 ± 0.60 a | 59.37 ± 0.45 a | |
T1 | 27.38 ± 1.58 a | 7.44 ± 1.29 a | 68.45 ± 0.59 b | 47.77 ± 1.12 b | 19.5 |
T2 | 27.38 ± 2.15 a | 7.44 ± 1.44 a | 54.76 ± 1.57 c | 34.97 ± 2.43 c | 41.1 |
T3 | 29.17 ± 0.60 a | 7.74 ± 0.52 a | 44.65 ± 3.72 d | 30.36 ± 1.80 c | 50.9 |
CK Control group with no inoculation, T1 treatment with 106 cfu/mL bacterial suspension of HX-140, T2 treatment with 107 cfu/mL, T3 treatment with 108 cfu/mL bacterial suspension of HX-140
a The lowercase letters in the table indicate significant differences between treatments (P < 0.05)